ABBOTT LABORATORIES (ABT)
Clinical trial NCT05333068 updates: 1. primary completion date: 2026-03-16 → 2026-09-16 2. enrollment: 1222 → 1223 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05333068 updates: 1. primary completion date: 2026-03-16 → 2026-09-16 2. enrollment: 1222 → 1223 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical